Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Click Therapeutics And Indivior Collaborate On Prescription Digital Therapeutics In Substance Use Disorder

Sep 07 2023

• By Marion Webb

(Shutterstock)

Related Content

The Afterlife Of Pear Therapeutics: Korean DTx Maker Discusses Vision For Salvaged Migraine Assets

Jun 12 2023

Digital Health Round-Up: DTA 2023 Highlights; Pear Assets; Medtronic’s Spin-Off; New Business

Jun 28 2023

Related Companies

Click Therapeutics, Inc.

Indivior plc

Otsuka Pharmaceutical Co. Ltd.

Verily

Boehringer Ingelheim Pharma KG

Additional Topics

Artificial Intelligence Behavioral Health Digital Health Clinical Trials Business Strategies Research & Development Commercial Neurology Diagnostics Patient Monitoring Medical Device

More from AI

More from Digital Technologies

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.